In a world where sustainability is increasingly relevant, it is essential to integrate effective measures that contribute to the protection of the environment. This challenge takes on special importance in the pharmaceutical industry, one of the most energy-intensive industrial sectors, where efficiency directly impacts competitiveness and regulatory compliance. To address this challenge, pharmaceutical companies need to find solutions that allow them to reduce their emissions and dependence on conventional energy sources without compromising the levels of quality, safety and reliability that characterize the sector. One of the most effective ways is the use of intelligent energy management solutions in buildings and industrial facilities. At Edison Next, we have been helping pharmaceutical companies advance their decarbonization plans for years through solutions such as Building Management Systems (BMS), a technological tool that enables real-time monitoring, control and optimization of energy use in buildings and plants. Thanks to this solution, air conditioning, ventilation, lighting and auxiliary processes can be integrated under a single digital platform, achieving significant savings and greater operational efficiency. In addition to maximizing energy efficiency, these systems also improve control over critical processes, especially in sectors where thermal stability and traceability are fundamental, such as the pharmaceutical industry. They also make it possible to detect consumption deviations, anticipate potential incidents and make decisions based on real data. This tool can be complemented by other thermal decarbonization technology solutions, such as electric boilers, hybrid boilers, high-temperature heat pumps or heat recovery systems. These technologies, adapted to the specific needs of each plant, allow for a significant reduction in emissions associated with heat production, one of the industry’s greatest challenges. The industrial heat pump, for example, is today one of the most efficient technologies for decarbonizing thermal demand, with performance levels far superior to those of traditional technologies. For processes operating below 100°C, mature commercial solutions already exist, while advances in very high-temperature heat pumps (VHTHP) are expanding their applicability in more demanding environments. In industries with high thermal loads and many annual operating hours, investment in these technologies becomes particularly cost-effective, even more so when combined with incentive mechanisms such as Energy Saving Certificates (CAEs). At Edison Next, in addition to designing and implementing these solutions, we also handle the certification and validation of the energy savings generated, facilitating their conversion into economic resources through mechanisms such as CAEs. This allows our clients to directly recover part of their investment, improving the economic viability of their sustainability plans. Our work always starts with an individualized analysis of each client and each facility. There is no single solution, because every plant has different characteristics, constraints and opportunities. That is why we combine our technical expertise with an in-depth knowledge of the regulatory and economic environment, to offer a realistic and ambitious roadmap towards decarbonization. With our advanced energy management, digitalization and thermal decarbonization solutions, we help pharmaceutical companies improve the efficiency of their facilities, reduce their environmental footprint and move towards a more competitive, sustainable model aligned with European standards. The future of the sector lies in embracing smart, clean and cost-effective technologies. And at Edison Next, we are ready to accompany them on that journey.